Abstract
Objective: Investigate evidence on types of interventions, emphasizing pharmaceutical interventions, and their respective clinical, epidemiological, access, humanistic and economic outcomes in patients with HIV / AIDS in medium complexity care. Methods: Systematic review and narrative synthesis. Results: there is evidence that professional, financial, governmental and multifaceted pharmaceutical interventions improve clinical, epidemiological, access and equity, humanistic and economic outcomes in people with HIV / AIDS in medium complexity care. Results: There is evidence that professional, financial, governmental and multifaceted pharmaceutical interventions improve clinical, epidemiological, access and equity, humanistic and economic outcomes in people with HIV / AIDS in medium complexity care. Final considerations: Several pharmaceutical interventions for people with HIV / AIDS have been shown to be important in improving clinical, epidemiological, humanistic and access and equity outcomes, thus pharmaceutical care has been shown to be important in strengthening strategies for the rational use of medicines and promoting quality improvement of the patient's life.